Healthcare Interoperability
Why Health Information Exchanges (HIEs) Still Struggle With Data Quality — and How to Fix It
Published November 19, 2026 · Influrion Editorial Team
Health Information Exchanges promised a shared longitudinal record across hospitals, clinics, labs, and public-health partners. Many networks now move ADT feeds, CCDs, and FHIR bundles every day—yet clinicians still open the viewer and see duplicate patients, stale allergies, conflicting meds, and lab results that cannot be charted without a phone call. Influrion Solutions builds healthcare interoperability software for organizations that need the exchange to be trustworthy, not merely connected.
Connection is table stakes. Data quality is what decides whether an HIE is a clinical asset or an expensive inbox of noise. This guide breaks down the root causes CIOs and digital-transformation leads actually see, then lays out a fix path that fits real HL7 v2 / CDA / FHIR estates—not a greenfield fantasy.
What “data quality” means for an HIE
In analytics, quality often means completeness and schema conformance. For an HIE serving care teams, quality is four questions answered before the clinician trusts the pane:
- Is this the right person? Identity match confidence, not just a demographic string.
- Is this the right meaning? Codes, units, and clinical context that survive crosswalks.
- Is this current enough? Temporal validity for allergies, meds, problems, and encounters.
- Can we prove where it came from? Provenance so disputed facts can be traced and corrected.
If any of those fail, the network’s technical uptime metrics can look green while adoption stays flat.
| Quality dimension | Typical HIE symptom | Clinical risk |
|---|---|---|
| Identity | Split / overlay charts | Wrong patient context |
| Vocabulary | Unmapped local codes | Missed allergies, unusable labs |
| Timeliness | Overnight batch only | Decisions made on stale state |
| Provenance | “Unknown source system” | No safe reconciliation path |
| Completeness | Empty sections in CCD/FHIR | False sense of “nothing documented” |
Why HIEs still struggle (root causes)
1. Identity was treated as a one-time MPI project
Most networks stood up a Master Patient Index early, then treated it as done. Reality: registration practices differ by facility, ambulatory EMR demographics lag, and pediatric / newborn / trauma edge cases keep producing overlays and splits. Without continuous linkage review, gold-card matching rules, and feedback from chart-correction workflows, the MPI drifts.
Fix signal: track overlay rate, split rate, and “manual merge queue age” as product KPIs—not only match percentage at go-live.
2. Vocabulary crosswalks stop at “good enough for certification”
US Core, LOINC, SNOMED CT, and RxNorm appear in RFPs. In production, labs still send local codes, pharmacies invent sig text, and problem lists mix ICD-10 with free text. Interfaces “pass” because the message is structurally valid, while the semantic payload is empty for downstream decision support.
3. Transport maturity outpaced content governance
Interface engines and FHIR gateways improved. Governance did not keep pace. Without a clear owner for each clinical domain (allergies, meds, labs, problems), every participant invents their own “minimum viable CCD.” The HIE becomes a union of inconsistent document habits, not a curated clinical network.
4. Batch-first design collides with acute care
Many HIEs still lean on nightly CCD dumps or delayed ADT. ED and inpatient workflows need near-real-time ADT, orders, and results. When the exchange is hours behind the source EHR, clinicians stop opening it—quality metrics worsen because usage collapses, not only because fields are wrong.
5. No closed-loop correction path
When a nurse finds a wrong allergy in the HIE viewer, where does the correction go? If the answer is “email the help desk,” quality never improves. High-performing networks treat quality as a product loop: detect → assign → correct at source → re-publish → verify.
6. Participant incentives are misaligned
Hospitals are measured on their own EHR quality. Contributing clean data to a regional exchange is rarely on the CIO scorecard. Without contracts, dashboards, and gentle peer pressure, the HIE inherits the lowest common denominator of participant discipline.
7. Tooling stops at connectivity dashboards
Ops teams can show message success rates and FHIR HTTP 200s. Clinicians need domain-level quality: allergy mapping coverage, med reconciliation conflicts, lab unit failures, and identity confidence on the last N chart opens. When the only green lights are transport lights, leadership underestimates the remediation backlog.
A practical architecture for better HIE data
Think in layers. Skipping a layer is how networks end up with pretty FHIR endpoints and unusable charts.
Edge intake and structural validation
- Accept HL7 v2, CDA/CCD, and FHIR R4 where participants can support them
- Reject (or quarantine) messages that fail schema, required fields, or size limits
- Log every rejection with a participant-facing reason code—not a silent drop
Identity and linkage services
- Probabilistic + deterministic matching with auditable scores
- Human review queues for borderline cases
- Stable network identifiers that do not overwrite source MRNs
- Overlay/split detection jobs after every major registration change
Semantic normalization
- Code system catalogs per domain (labs, meds, allergies, problems)
- Participant-specific crosswalks with versioning
- Unit normalization and reference-range handling for labs
- Explicit “unmapped” status—never invent a SNOMED code to look compliant
Clinical content rules
- Domain stewards define required elements for each use case (ED summary, meds refill, care coordination)
- Profile validation (US Core or regional IG) on publish, not only on receive
- Prefer discrete FHIR resources for high-value domains; keep documents as fallback, not the only path
Provenance, consent, and audit
- Every assertion carries source organization, system, and timestamp
- Consent and purpose-of-use checked before display or secondary use
- Immutable audit for access and correction events
Feedback and remediation
- Quality scorecards per participant and per domain
- Ticketing that opens at the source EMR owner, not only at the HIE ops team
- Re-ingest verification after correction
Fix path CIOs can run in 90 days
You will not rewrite every interface in a quarter. You can change the trajectory.
Days 1–30: Measure what clinicians already hate
- Pick three high-pain domains (usually allergies, medications, labs).
- Sample 50–100 real chart opens (with privacy controls) and score: identity confidence, mapping completeness, freshness, provenance present.
- Publish a one-page scorecard to participant CIOs—peer visibility beats another vendor slide deck.
- Instrument the viewer: open rate, time-to-first-interaction, “report data issue” clicks.
Days 31–60: Close the worst loops
- Stand up a data quality queue with SLAs (e.g., overlays reviewed in 48 hours).
- Fix the top five unmapped lab codes that break the most charts.
- Require ADT freshness SLAs for acute sites (minutes, not overnight).
- Add “report incorrect data” from the viewer with auto-routing to the source site’s interface owner.
Days 61–90: Harden contracts and product rules
- Update participation agreements with minimum content rules for the three domains.
- Gate new consumer apps on quality thresholds (e.g., allergy mapping ≥ X% for their patient cohort).
- Move high-value domains toward discrete FHIR publication where feasible.
- Review MPI gold cards and matching thresholds with HIM leadership—not only IT.
Checklist: what “good” looks like
Use this as a buyer / board checklist when evaluating HIE platforms or a remodeled internal exchange.
- Overlay and split rates are tracked weekly and trending down
- Unmapped codes are visible per participant—not hidden inside “valid” messages
- Allergies, meds, and labs have named domain stewards
- Acute ADT / results latency meets an explicit SLA
- Provenance is visible in the clinician UI for disputed facts
- Clinicians can report errors without leaving the workflow
- Corrections re-publish and are verified, not only ticketed
- Consumer apps fail closed when identity confidence is below threshold
- Quality scorecards are shared with participant leadership monthly
- FHIR/CDA profiles are validated on write, not only advertised in CapabilityStatements
Buyer questions for HIE vendors and integrators
- How do you detect and remediate patient overlays after go-live—not only during MPI cutover?
- What percentage of lab observations in production map to LOINC with units normalized—and can we see the unmapped tail?
- Where does a clinician-reported allergy error land, and what is the median time to corrected re-publish?
- Do you validate US Core / regional profiles on ingest, or only expose a FHIR façade?
- How is freshness measured for ADT and results for ED use cases?
- Can we export quality scorecards per participant for governance meetings?
- What happens when two sources disagree on a medication—merge, prefer source, or show conflict?
Influrion Solutions helps networks answer these with integration architecture, FHIR/HL7 adapters, and operational tooling—not by pretending a single vendor console replaces clinical governance.
Pitfalls to avoid
- Chasing “100% FHIR” while ignoring identity. Clean resources on the wrong patient are worse than messy documents on the right one.
- Silent message drops. Participants cannot improve what they cannot see.
- One-time crosswalk projects. Vocabularies drift; treat mapping as a living product.
- Analytics lakes as a substitute for clinical quality. Warehouses help population health; they do not fix the ED viewer.
- Punitive scorecards without remediation capacity. Shame without staffing produces gaming, not better data.
FAQ
Why do HIEs still have bad data after years of investment?
Because most investment went into connectivity and compliance demos, while identity maintenance, vocabulary ownership, freshness SLAs, and closed-loop corrections lagged. The pipes got better; the content governance did not.
Is FHIR enough to fix HIE data quality?
No. FHIR improves structure and app access, but quality still depends on MPI discipline, code mapping, provenance, and participant incentives. A FHIR façade over dirty sources is still dirty—just JSON-shaped.
Should we rebuild our HIE or remediate in place?
Most networks should remediate in place: measure clinical pain, close correction loops, harden contracts, then selectively modernize high-value domains to discrete FHIR. Full rip-and-replace rarely fixes governance gaps that caused the quality failure.
Who should own HIE data quality—IT or HIM/clinical informatics?
Both. IT owns transport, validation, and tooling; HIM and clinical informatics own identity policy and domain meaning. Without a joint operating model, scorecards stall.
How does Influrion Solutions help with HIE quality programs?
Influrion Solutions is a software and healthcare-IT company that designs and builds interoperability components—HL7/FHIR interfaces, normalization services, and operational workflows—so exchanges can measure quality, enforce profiles, and close correction loops with their participants.
Closing
HIE value is not measured by message volume. It is measured by whether a clinician trusts the record enough to use it under pressure—especially in ED handoffs, medication reconciliation, and cross-facility care coordination. Fix identity drift, semantic mapping, freshness, provenance, and the correction loop—and the same network that “struggled with data quality” becomes a reliable care coordination surface.
If you are planning an HIE quality remediation or FHIR modernization program, contact Influrion Solutions to discuss architecture and integration options that fit your current participant landscape.
